[INARI] QoQ Cumulative Quarter Result on 31-Mar-2023 [#3]

Stock
[INARI] INARI AMERTRON BERHAD
Announcement Date
25-May-2023
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2023
Quarter
31-Mar-2023 [#3]
Profit Trend
QoQ- 28.7%
YoY- -15.58%
Quarter Report
Latest QR
Upcoming QR
INARI's Result
INARI's Financial Summary
View:
Show?
Cumulative Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 798,008 383,932 1,354,003 1,055,251 779,456 377,000 1,547,899 -35.62%
PBT 180,047 89,717 355,776 283,164 221,270 121,057 446,109 -45.29%
Tax -8,118 -4,388 -30,751 -26,376 -21,742 -14,678 -54,916 -71.94%
NP 171,929 85,329 325,025 256,788 199,528 106,379 391,193 -42.10%
-
NP to SH 171,787 84,978 323,535 257,223 199,861 106,252 390,917 -42.11%
-
Tax Rate 4.51% 4.89% 8.64% 9.31% 9.83% 12.12% 12.31% -
Total Cost 626,079 298,603 1,028,978 798,463 579,928 270,621 1,156,706 -33.50%
-
Net Worth 2,645,888 2,634,369 2,602,513 2,551,805 2,576,010 2,581,379 2,504,245 3.72%
Dividend
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Div 164,782 82,207 306,090 231,439 179,174 96,472 370,669 -41.66%
Div Payout % 95.92% 96.74% 94.61% 89.98% 89.65% 90.80% 94.82% -
Equity
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Net Worth 2,645,888 2,634,369 2,602,513 2,551,805 2,576,010 2,581,379 2,504,245 3.72%
NOSH 3,747,167 3,743,747 3,732,934 3,732,934 3,731,076 3,713,129 3,707,354 0.71%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin 21.54% 22.23% 24.00% 24.33% 25.60% 28.22% 25.27% -
ROE 6.49% 3.23% 12.43% 10.08% 7.76% 4.12% 15.61% -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
RPS 21.31 10.27 36.27 28.27 20.88 10.16 41.76 -36.06%
EPS 4.59 2.27 8.68 6.90 5.37 2.86 10.65 -42.85%
DPS 4.40 2.20 8.20 6.20 4.80 2.60 10.00 -42.06%
NAPS 0.7065 0.705 0.6972 0.6836 0.6901 0.6957 0.6756 3.01%
Adjusted Per Share Value based on latest NOSH - 3,732,934
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
RPS 21.06 10.13 35.74 27.85 20.57 9.95 40.86 -35.63%
EPS 4.53 2.24 8.54 6.79 5.28 2.80 10.32 -42.15%
DPS 4.35 2.17 8.08 6.11 4.73 2.55 9.78 -41.64%
NAPS 0.6984 0.6953 0.6869 0.6735 0.6799 0.6814 0.661 3.72%
Price Multiplier on Financial Quarter End Date
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Date 29/12/23 29/09/23 30/06/23 31/03/23 30/12/22 30/09/22 30/06/22 -
Price 3.01 2.90 2.74 2.46 2.61 2.52 2.64 -
P/RPS 14.13 28.22 7.55 8.70 12.50 24.80 6.32 70.73%
P/EPS 65.62 127.52 31.61 35.70 48.75 88.00 25.03 89.79%
EY 1.52 0.78 3.16 2.80 2.05 1.14 3.99 -47.35%
DY 1.46 0.76 2.99 2.52 1.84 1.03 3.79 -46.96%
P/NAPS 4.26 4.11 3.93 3.60 3.78 3.62 3.91 5.86%
Price Multiplier on Announcement Date
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Date 26/02/24 22/11/23 29/08/23 25/05/23 24/02/23 17/11/22 19/08/22 -
Price 3.16 3.00 3.03 2.26 2.45 2.58 2.86 -
P/RPS 14.83 29.20 8.35 7.99 11.73 25.39 6.85 67.11%
P/EPS 68.89 131.92 34.96 32.80 45.76 90.10 27.12 85.85%
EY 1.45 0.76 2.86 3.05 2.19 1.11 3.69 -46.25%
DY 1.39 0.73 2.71 2.74 1.96 1.01 3.50 -45.87%
P/NAPS 4.47 4.26 4.35 3.31 3.55 3.71 4.23 3.73%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment